Ventricular rate stabilization for the prevention of pause dependent ventricular tachyarrhythmias: Results from a prospective study in 309 ICD recipients

PACE - Pacing and Clinical Electrophysiology

Volumn 25, Issue 12, 2002, Pages 1708-1714

  Grönefeld, Gerian C ^a   Israel, Carsten W ^a   Padmanabhan, Vasant ^a,b,c   Koehler, Jodi ^a,b,c   Cuijpers, Antoine ^a,b,c   Hohnloser, Stefan H ^a,d  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

^c MEDTRONIC INC   (United States)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

Implantable cardioverter defibrillator; Pacing; Pathophysiology; Therapy; Ventricular tachycardia

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEFIBRILLATOR; ELECTROGRAPHY; FEMALE; FOLLOW UP; HEART PACING; HEART VENTRICLE CONTRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT INDICATION; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 0036910817     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2002.01708.x     Document Type: Article

References (27)

1. Connolly SJ, Gent M, Roberts RS, et al. Canadian Imptantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101:1297-1302.
2. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-1583.
3. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J 2000; 21:2071-2078.
4. Sarter B, Callans D, Gottlieb CD, et al. Implantable defibrillator diagnostic storage capabilities: Evolution, current status, and future utilization. PACE 1998; 21:1287-1298.
5. Grubman EM, Pavri BB, Shipman T, et al. Cardiac death and stored electrograms in patients with third-generation implantable cardioverter-defibrillators. J Am Coll Cardiol 1998; 32:1056-1062.
6. Taylor E, Berger R, Hummel JD, et al. Analysis of the pattern of initiation of sustained ventricular arrhythmias in patients with implantable defibrillators. J Cardiovasc Electrophysiol 2000; 11:719-726.
7. Gronefeld G, Hohnloser SH. What do implantable cardioverter/defibrillators teach us about the mechanisms of sudden cardiac death? Cardiovasc Res 2001; 50:232-241.
8. Kakishita M, Kurita T, Matsuo K, et al. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000; 36:1646-1653.
9. nd Ed. Philadelphia, WB Saunders, 1995, pp. 863-877.
10. Meyerfeldt U, Schirdewan A, Wiedemann M, et al. The mode of onset of ventricular tachycardia. A patient-specific phenomenon. Eur Heart J 1997; 18:1956-1965.
11. Roelke M, Garan H, McGovern BA, et al. Analysis of the initiation of spontaneous monomorphic ventricular tachycardia by stored intracardiac electrograms. J Am Colt Cardiol 1994; 23:117-122.
12. Viskin S, Alla SR, Baron HV, et al. Mode of onset of torsade de pointes in congenital long QT syndrome. J Am Coll Cardiol 1996; 28:1262-68;
13. Viskin S, Fish R. Roth A, et al. Prevention of torsade de pointes in the congenital long QT syndrome: Use of a pause prevention pacing algorithm. Heart 1998; 79:417-419.
14. Viskin S, Glikson M, Fish R, et al. Rate smoothing with cardiac pacing for preventing torsade de pointes. Am J Cardiol 2000; 86:K111-K115.
15. Fisher JD, Teichman SL, Ferrick A, et al. Antiarrhythmic effects of VVI pacing at physiologic rates: A crossover controlled evaluation. PACE 1987; 10:822-830.
16. Johnson RA, Hutter AM, Desanctis RW, et al. Chronic overdrive pacing in the control of refractory ventricular arrhythmias. Ann Intern Med 1974; 80:380-383.
17. Winter UJ, Behrenbeck DW. Hemodynamic and anti-ectopic effects of long term dynamic overdrive pacing in implanted VVI pacemakers. In DW Behrenbeck, E Sowton, G Fontaine, UJ Winters (eds.): Cardiac Pacemakers. New York, Springer-Verlag, 1985.
18. Daubert JC, Prystowsky EN, Ripart A. Prevention of Tachyarrhythmias with Cardiac Pacing. Armonk, NY, Futura Publishing Company, Inc., 1997.
19. Fromer M, Wietholt D. Algorithm for the prevention of ventricular tachycardia onset: The Prevent Study. Am J Cardiol 1999; 83:45D-47D.
20. Gregoratos G, Cheitlin MD, Conill A, et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: Executive summary-a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). Circulation 1998; 97:1325-1335.
21. Wilkoff BL, Kuhlkamp V, Volosin K, et al. Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection: Results and technical considerations. Circulation 2001; 103:381-386.
22. Saeed M, Link MS, Mahapatra S, et al. Analysis of intracardiac electrograms showing monomorphic ventricular tachycardia in patients with implantable cardioverter-defibrillators. Am J Cardiol 2000; 85:580-587.
23. Efron B. The jackknife, the bootstrap and other resampling plans. CBMS-NSF Regional Conference. Series in Applied Mathematics, Volume 38 (1982). 82 A.D.
24. Andersen PK, Borgan O, Gill RD, et. al. Statistical models based on counting processes. New York, Springer-Verlag, 1992.
25. el Sherif N, Turitto G. The long QT syndrome and torsade de pointes. PACE 1999; 22:91-110.
26. Denker S, Lehmann M, Mahmud R, et al. Facilitation of ventricular tachycardia induction with abrupt changes in ventricular cycle length. Am J Cardiol 1984; 53:508-515.
27. Grimm W, Hoffmann J, Menz V, et al. Prevention of recurrent ventricular fibrillation by ventricular rate stabilization. Europace 2000; 2:346-349.